Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. In recent years, pharmaceutical companies have broadened their horizons, moving beyond drug ...

The Drug Device Combination Products Market is poised for robust growth over the next decade, with its market value estimated ...

The second quarter of 2025 was a period of dynamic evolution within the biotech and pharma sectors. Critical factors like escalating policy pressures, pipeline pivots by leading companies and the ...

Roche Holding and AstraZeneca were among those companies posting increases as European pharma stocks tracked gains in the U.S. on Tuesday.